Gastric Neuroendocrine Neoplasms: Clinical Management and Outcomes in a Cohort of 54 Patients Abstract #2711

Introduction: Gastric NENs are increasingly being diagnosed at endoscopy. The majority of these are type 1 gastric NEN. However, around 10-20% can be type 3 or type 4 Gastric NENs.
Aim(s): Comparing different types of Gastric NENs to investigate their management and outcomes
Materials and methods: A retrospective review performed of 54 patients with gastric NENs referred to a tertiary centre during 2014 to 2019.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Surgical treatment and Ablative Therapies
Presenting Author: Alexandra Victor

To read results and conclusion, please login ...

Further abstracts you may be interested in

#2709 Endoscopic Management and Outcomes of Gastro-Duodenal Neuroendocrine Tumours
Introduction: Gastric and duodenal neuroendocrine tumours are increasing in incidence. ENETS guidelines suggest endoscopic resection of type 1 gastric NENs over 10mm and consider endoscopic resection for duodenal NENs. However, the endoscopic techniques are not clearly mandated. There, is evidence to suggest endoscopic mucosal dissection has higher incidence of R0 resections compared with polypectomy or EMR alone.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Endocrine malignancies (MTC, pheochromocytoma) - diagnosis and therapy
Presenting Author: Alexandra Victor
#2760 Management and Outcomes of Duodenal Neuroendocrine Tumours
Introduction: Duodenal NENs (D-NENs) are increasing in incidence often incidentally identified at endoscopy. ENETS guidelines suggest endoscopic resection for duodenal NETs <1cm if not periampullary.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Surgical treatment and Ablative Therapies
Presenting Author: Alexandra Victor
#1890 Natural History of Type 1 Gastric Carcinoid (gNENs) and Risk of Adenoma/Adenocarcinoma in Endoscopic Surveillance Programme
Introduction: Patients with gNENs & autoimmune gastritis are exposed to 2 malignant risks: 1)transformation of gNENs, felt to be low & guidelines advocate either resection of all lesions or selective endoscopic mucosal resection(EMR) of larger lesions; 2)ill-defined risk of gastric adenoma/adenocarcinoma.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: MD, MRCPI, MRCP Jun Liong Chin
Keywords: Type 1 g-NENs
#1633 The Preoperative Blood Lymphocyte-To-Monocyte Ratio Acts As a Superior Prognostic Factor and Predicts Tumor Metastasis in Gastric Neuroendocrine Neoplasms after Surgery
Introduction: A low lymphocyte-to-monocyte ratio (LMR) has been reported to be a predictor of poor survival in patients with various cancers but has not been examined in patients with gastric neuroendocrine neoplasms (g-NENs).
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: Huang Chang-Ming
#1634 Trends of Incidence and Survivals for Gastric Neuroendocrine Neoplasms: An Analysis of 3523 Patients in the SEER Database
Introduction: The published evidence on gastric neuroendocrine neoplasms (g-NENs) is often based on small series of patients.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: Huang Chang-Ming